STOCKHOLM — Akinion Pharmaceuticals AB has appointed Carl Harald Janson as its new CEO, according to a press release.
Carl Harald Janson, MD, PhD and CEFA, has over 25 years of experience in medicine, pharmaceutical development and asset management.
"We are very pleased to see Carl Harald Janson as new CEO in Akinion," said Ingemar Aldén, chairman of Akinion. "Carl Harald has been a board member of Akinion since its inception. His broad experience in pharmaceutical development will be of great benefit to the company."